AI assistant
Sending…
CorMedix Inc. — Director's Dealing 2010
Mar 26, 2010
32333_dirs_2010-03-26_7fdeb076-11cc-4c58-a4ed-2c42f7782b85.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2010-03-24
Reporting Person: Houghton John C. (Director, President and CEO)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $0.001 par value per share | 13528 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $8.2300 | 2018-08-01 | Common Stock, $0.001 par value per share (1915) | Direct |
Footnotes
F1: These options vest as follows: 1/3 on March 4, 2009; an additional 1/3 on March 4, 2010; and the remaining 1/3 on March 4, 2011.
More from CorMedix Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 27